{"disease":{"id":"bacterial-diseases","name":"bacterial diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06833957","title":"Preparing for Maternal GBS Vaccine Trials in Africa","phase":"","overall_status":"RECRUITING","enrollment_count":18100,"lead_sponsor_name":"Barcelona Institute for Global Health","has_results":false},{"nct_id":"NCT06322290","title":"Epidemiological Study on Invasive Bacterial Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Meyer Children's Hospital IRCCS","has_results":false},{"nct_id":"NCT01340937","title":"A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2808,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01337167","title":"Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1473,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01480258","title":"Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1315,"lead_sponsor_name":"MCM Vaccines B.V.","has_results":true},{"nct_id":"NCT01341639","title":"Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1250,"lead_sponsor_name":"MCM Vaccines B.V.","has_results":true},{"nct_id":"NCT04762134","title":"Doxycycline Intervention for Bacterial STI ChemoprOphylaxis (DISCO)","phase":"NA","overall_status":"RECRUITING","enrollment_count":560,"lead_sponsor_name":"Jonathan Troy Grennan","has_results":false},{"nct_id":"NCT04952337","title":"Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Hannover Medical School","has_results":false},{"nct_id":"NCT01839188","title":"Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":385,"lead_sponsor_name":"MCM Vaccines B.V.","has_results":true},{"nct_id":"NCT01553279","title":"Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"MCM Vaccines B.V.","has_results":true},{"nct_id":"NCT05307991","title":"Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe","phase":"","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT05153694","title":"Infectious Complications After Cystectomy: A Prospective Observational Study","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT04485676","title":"Dalbavancin in Real Clinical Practice in Spain","phase":"","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Angelini Farmacéutica","has_results":false},{"nct_id":"NCT05788991","title":"Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":151,"lead_sponsor_name":"Medinova AG","has_results":true},{"nct_id":"NCT03590600","title":"A Single Ascending Dose Study of BTZ043","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Michael Hoelscher","has_results":false},{"nct_id":"NCT06451172","title":"Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT05294146","title":"Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04874948","title":"Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Michael Hoelscher","has_results":true}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}